Recently, driven by breakthrough progress in global brain-computer interface (BCI) technology, stocks related to BCI have surged collectively on China’s A-share and Hong Kong markets. Companies involved in neuroscience, artificial intelligence, medical devices, and chip development saw significant share price increases, with some rising over 10% in a single day. This rally was largely triggered by Neuralink—Elon Musk’s neurotechnology company—announcing the success of its first human implantation surgery and receiving FDA approval for expanded clinical trials. The market interprets this as a sign that BCI technology is transitioning from lab research to real-world applications, holding immense potential for treating neurological conditions such as paralysis, epilepsy, and depression.Moreover, Chinese authorities have prioritized BCI and other frontier technologies in national strategies. The country’s 14th Five-Year Plan for Bioeconomic Development explicitly supports brain science and brain-inspired research, with multiple local governments rolling out targeted incentives to foster industry-academia collaboration. As a result, listed companies with core technical capabilities or strong research partnerships are attracting significant investor interest.However, experts caution against excessive speculation. BCI remains in its early developmental stage, with unclear commercialization pathways and most related firms yet to turn a profit. Short-term hype may inflate valuations, and investors are advised to rationally assess the gap between technological promise and actual investment value.
近日，受全球脑机接口技术取得突破性进展的利好消息刺激，A股及港股市场中与脑机接口相关的概念股集体暴涨。多家涉及神经科学、人工智能、医疗设备及芯片研发的企业股价大幅上扬，部分个股单日涨幅超过10%。这一轮上涨主要源于马斯克旗下Neuralink公司宣布其首例人体植入手术成功，并已获得美国FDA批准开展更大规模临床试验。市场普遍认为，这标志着脑机接口技术正从实验室走向实际应用，未来在治疗瘫痪、癫痫、抑郁症等神经系统疾病方面具有巨大潜力。此外，国内政策层面也对脑机接口等前沿科技给予高度重视。《“十四五”生物经济发展规划》明确提出支持脑科学与类脑研究，多地政府相继出台专项扶持政策，推动产学研协同创新。在此背景下，具备核心技术储备或与科研机构深度合作的上市公司备受资本青睐。不过，专家也提醒投资者注意风险。目前脑机接口仍处于早期发展阶段，商业化路径尚不清晰，多数相关企业尚未实现盈利。短期炒作情绪可能推高估值泡沫，建议理性看待技术前景与投资价值之间的差距。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/8979.html